All stock lists
Puma Biotechnology, Inc. (NASDAQ:PBYI)
US · Delayed Price · Currency is USD
10.85-0.17 (-1.59%)
Insider Score
––Not scored
PBYI Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
PBYI Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 56.50 M | 44.81 M | 75.45 M | 54.48 M | 52.44 M | 46.01 M |
| Revenue Growth (YoY) | 7.75 % | -2.59 % | 27.72 % | -32.36 % | 11.37 % | 5.12 % |
| Cost of Revenue | 12.47 M | 10.42 M | 23.13 M | 12.17 M | 12.30 M | 10.56 M |
| Gross Profit | 44.03 M | 34.39 M | 52.33 M | 42.30 M | 40.13 M | 35.45 M |
| SG&A Expense | 17.55 M | 18.42 M | 18.38 M | 17.03 M | 18.41 M | 17.39 M |
| R&D Expense | 18.89 M | 19.80 M | 16.84 M | 15.91 M | 15.45 M | 13.86 M |
| Operating Expenses | 36.44 M | 38.22 M | 35.22 M | 32.73 M | 33.50 M | 31.47 M |
| Operating Income | 7.58 M | -3.83 M | 17.11 M | 9.57 M | 6.64 M | 3.98 M |
| Pretax Income | 8.24 M | -3.43 M | 17.11 M | 9.24 M | 6.17 M | 3.27 M |
| Tax Provision | 56.00 K | 326.00 K | 3.67 M | 399.00 K | 310.00 K | 293.00 K |
| Net Income | 8.19 M | -3.75 M | 13.44 M | 8.84 M | 5.86 M | 2.97 M |
| EPS (Basic) | 0.16 | -0.07 | 0.27 | 0.18 | 0.12 | 0.06 |
| EPS (Diluted) | 0.16 | -0.07 | 0.26 | 0.17 | 0.12 | 0.06 |
| Shares Outstanding | 50.94 M | 50.85 M | 50.34 M | 50.34 M | 49.70 M | 49.60 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.